Rats, mice, and rhesus monkeys were subjected in subchronic exposures to the chemicals p-chlorophenyl methyl sulfide, p-chlorophenyl methyl sulfoxide, and p-chlorophenyl sulfone. Ninety-one-day toxicity studies were conducted by administering test chemicals to rodents at dietary concentrations of 750, 1500, and 3000 ppni. Clinical signs observed included transient central nervous system (CNS) depression, anorexia, and depressed weight gains. Minor alterations of hematologic and clinical chemistry parameters were also present. Gross and microscopic tissue findings in mice and rats included enlargement, necrotic and megalocytic changes of the liver. Damage to bronchiolar epithelium was observed in mice only at the highest exposure level. A 14-day gavage study in monkeys used daily dosages' ranging from 2.5 to 80 m a g with an additional 15 days allotted for a recovery phase in one-half the test animals.
INTRODUCTION
HREEPHENYL h i m m L A T E D SULFUR CHEhllCALS identified in water and soil samples from the area near a former T nitralin herbicide manufacturing facility at the Rocky hlountain Arsenal in Colorado were subjected to toxicologic assessments. The first paper (teberet al.. 1993 ) in a series of three in this journal reported a relatively low acute toxicity and lack of mutagenic activity for the chemicals p-chlorophenyl methyl sulfide ("sulfide"), p-chlorophenyl methyl sulfoxide ("sulfoxide"), and p-chlorophenyl methyl sulfone ("sulfone"). ~ 'Rodents of each speciedeach gender administered sulfide, sulfoxide, sulfone. bControls for sulfide and sulfone studies. cControls for sulfoxide study. dControls for sulfide, sulfoxide, sulfone. 'All chemicals tested at 750 ppm; however, sulfone mouse groups were examined at 91 days only, and sulfide at 28 and 63 days. '5000 ppm sulfoxide administered only to mice; entire group died during weeks 1 and 2. €6000 ppm sulfide and sulfone administered only to mice; no mice in sulfide group survived to 91 days.
Rodents were observed twice daily for signs of clinical changes. Individual animal body weights and feed consumptions were recorded weekly. The metabolic efficiency of feed intake was calculated by dividing body weight gains (X 100) during that period by total feed consumption for the 91-day study. This parameter (expressed as percentage) differentiates the body weight gain decrements that result from decreased feed intakes from the direct toxic effects of administered chemicals.
Before initiating any study, and at the end of 91 days' exposure, electrocardiographic (ECG) and ophthalmic examinations were performed on six male and six female rats in control and high-dosage groups. Animals in the lower-dosage groups were not similarly examined since cardiac or eye changes were not observed in high-dosage groups for the test chemicals. The ECG measurements were made with a system of three simultaneous leads identified as I, aV,, and V,, using an hex amplifier. Recorded ECG information was interpreted by a consulting veterinary cardiologist.
Eye examinations were performed following dilatation of pupils with Mydriacil (Alcon Laboratories). Observations were made with a Welch Allyn direct ophthalmoscope for fundoscopic changes, and an American Optical slit-lamp biomicroscope for examination of the iris, lens, cornea, and conjunctivae. A veterinary ophthahologist performed all procedures.
Blood testing was performed on six male and six female rats from control and high-dosage groups following 28 and 63 days of exposure, and in all rats after 91 days' exposure. On days of necropsy, blood samples for hematologic analyses were collected from the orbital plexus. Following anesthetization with intraperitoneal injection of sodium pentobarbital prior to necropsy, a second blood sample was obtained by cardiac puncture. Following blood coagulation, serum specimens were collected for clinical chemistry determinations. Blood testing included the parameters listed in Table 2 .
Necropsies were performed on all rodents following anesthetization (CO, or sodium pentobarbital) and sacrifice by exsanguination. Forty major tissues plus gross lesions and tissue masses were collected and preserved in formalin (eyes in glutaraldehyde). Mouse and rat organs neighed in the 91-day exposure groups (including recovery animals) were heart, kidneys, adrenals, liver, seminal vesicles, testes with cpididymides. uterus, and brain. Thyroid and pituitary weights were also obtained for rats. All tissues collected in control and high-dosage groups at 28 and 91 days were processed histologically (staining with hematoxylin and eosin [H&E] ), and subjected to microscopic examination. When lesions were noted, that tissue was examined from animals at succeedingly lower dosages until the lesion was no longer present. Recovery groups were likewise examined only when the lesion was observed in nonrecovery animals.
Data analyses were performed by applying appropriate statistical tests. Bartlett's test for homogeneity of variance (Bartlett, 1937) was used to assess control and treated animal groups for body weight gains. feed Shirley (1977a,b) .
Forrrteen-day gavage study (rliesus monkeys)
Rhesus monkeys of both gender were procured from Primate Imports and placed into quarantine. Body weights, extensive clinical chemical and hematologic tests, ECGs, and eye examinations (with dilatation, funduscope, and slit-lamp biomicroscope) were conducted during the pretest period to establish baseline values. Animals were housed individually, and fed Purina Monkey Chow twice daily with water provided ad libitum.
Monkeys were treated with test chemicals by passing an infant feeding tube lubricated with jelly through the nasal cavity into the animals' stomachs. Chemicals dissolved or suspended in corn oil were administered daily for up to 14 days. Table 3 outlines the study design with timing and clinical condition of monkeys at necropsy. Dosage levels were adjusted according to individual body weights recorded on days I , 4, 7, 11. Clinical observations were made daily. Blood samples were collected prior to chemical exposures, on days 7 and 15, and days 21 and 29 for recovery animals. Blood samples were subjected to the same tests as listed above for rats with the following exceptions.
Blood tests conducted exclusivcly in rats were calculated mean corpuscular volumes, hemoglobin, and hemoglobin concentration. Tests conducted only in monkeys were platelets, reticulocyte counts, prothrombin times, creatinine, lactate dehydrogenase, total protein, inorganic phosphorus, glucose, sulfobromophthalein (BSP) retention.
On day 15 (1 day following final chemical dosing), approximately one-half of the monkeys in each test group were randomly chosen for necropsy while remaining animals were retained until day 29 to assess recovery from toxic effects. Immediately before postmortem examinations, each animal was subjected to blood, ocular, and ECG testing. Following necropsies, major tissues were weighed and processed for microscopic examinations.
RESULTS

Twenty-eight-day gavage sti.rcly in rats
Results indicated that the sulfide compound induced 100% mortality in rats at daily dosages of 220 mg/kg and above (data not shown). The lowest lethal dose (LD,) in males was 150 mglkg while the LD, for females was 37 For all three test chemicals, body weight gains for males were slightly suppressed in a dose-related manner whereas in females this parameter was not affected. Feed consumptions were not influenced by test chemicals in either gender. Pharmacotoxic symptoms were similar for all compounds. Rats exhibited immediate and marked depression of motor activity following daily treatments in test groups receiving dosages in excess of 50 mg/kg. In groups, rats progressively exhibited greater central depression until time of death. In animals surviving 28 days of treatment, evidence of pharmacotoxic tolerance was exhibited as symptoms of clinical depression were absent in the final weeks prior to study termination. Based on the data from the gavage studies, the relative toxicities were sulfide = sulfone > sulfoxide.
Twerity-eight-day dierary range-firdiiig sriidies
Rats. Mortality and growth data obtained from the study are given inTable 4. The lethal effects of the sulfide to 100% of the high-dosage (9000ppm) groupoccurred during the first week of exposure to sulfide, and was ascribed to starvation apparently due to lack of palatability of the treated diet. Substantial suppressions of body weight gains relative to controls (225%) during the 28-day study were observed in both genders at 560 and 2250 ppm dietary concentrations, and in females at 280 ppm.
The sulfoxide induced lethality in both genders at a dietary concentration of 5200 ppm. Concentrations of 1300
and 2600 ppm as well as sulfone (2250 ppm, male and female; 560 ppm, male) induced compound-related depressions in body weight gains (>25%). Fecd consumption values were markedly depressed in Weeks I and 2 for sulfide and sulfone compounds. Thereafter, tolerance to this effect developed as intake of the chemicalcontaining diets returned towards control levels (data not included). Liver (necrosis) and kidney (glomerulonephrosis) lesions were observed microscopically in high-dosage sulfone and sulfide rats. Mice. Results in the 28-day mouse dietary study are shown in Table 5 . Death was induced in week 1 only in females, and only by the highest levels of sulfide (4500 ppm) and sulfoxide (5200 ppm). Prior to death, these animals exhibited marked depression in motor activity, body weights, and feed consumptions. Body weights and feed consumption results did not follow clear dose-response patterns, apparently due to the fact that test mice were not within a rapid phase of growth as evidenced by small changes in control body weights (1.0-3.7 g) during the 4-week study period.
Histopathologic examinations of high-dosage mice showed predominantly a high incidence of hepatic congestion and megalocytosis. No-observable-effect levels (NOELS) for this study are unclear although these data provide a basis to project dietary levels appropriate for longer-term studies.
Ninety-one-day dietary stirdies
Rats. Body weights in all test groups were significantly depressed (relative to controls) in a dose-related manner for both'genders at all time points. Typical results for the three test materials are presented in Figure 1 , which depicts body weight changes for sulfoxide-treated males and females. Body weights of high-dosage rats moved towards control levels during the 2 recovery weeks postexposure (weeks 14 and 15).
Reduced feed and water intakes were observed during the exposure periods in the 3000 ppm groups for each of the test chemicals (data not shown). Clinical signs at this exposure level included ocular and nasal discharges, rough hair coat, and inactivity. Compound-related mortality was observed only in the 3000 ppm sulfoxide-treated males as 6 of 16 animals died in the interval from week 4 to 13. Animals dying were emaciated prior to death. One male rat in the 750 ppm sulfone group died from causes unknown. * I500 Po. Feed efficiencies (%) = (body weight changelfeed consumed over 13 week study period) X 100.
Sulfoxide Sulfone
Chemical exposures caused minimal hematologic changes (data not included). Results for sulfide-treated rats indicate a slight suppression of mean cellular volume, and increased mean cellular hemoglobin and cellular hemoglobin concentrations in both genders on the final day of chemical exposures with a modest trend towards control values occumng at the end of a 14-day recovery period. Similar results were seen for the sulfoxide and sulfone. Although changes were observed (up to 15% decline for hematocrits in sulfoxide-treated male rats), the lack of dose-responsiveness as well as an absence of microscopic findings in bone marrow suggest that these changes are not likely primary effects of the chemicals tested.
Clinical chemistry results (not shown) indicate a small decrease in serum levels of liver function enzymes (serum glutamic oxaloacetic transaminase [SGOT], SGPT, alkalinephosphatase). Blood urea nitrogen (BUN) values were elevated (up to 30%) immediately following 91-day exposures in sulfide-and sulfonc-treated males but these also lacked dose-response associations. Potassium and calcium levels were somewhat elevated in all treatment groups immediately upon completion of chemical exposures but were diminished in the sulfoxide 14-day recovery groups.
Microscopic examinations of livers of test animals showed a very high incidence of megalocytosis in all treatment groups (Table 7) . This finding is consistent with elevated liver weights observed in these animals. Whereas livedbody weight ratios ranged from 7.88 to 8.82 in 3000 ppm nonrecovery rats for all three compounds, values for recovery animals ranged from 3.9 to 4.7, indicating substantial reversion during the 14-day recovery period. Vacuolar cytoplasmic changes of the liver were induced by all chemicals with the highest incidences being observed in female rats. Focal necrotic lesions were sporadically seen across various treatment groups. No untoward effects related to chemical exposures were noted in kidneys.
A substantial number of other organs exhibited weight differences from control levels at time of sacrifice. However, upon normalization of organ weights to rat body weights, many of these differences disappeared. Organs exhibiting clear compound-related changes include kidneys (increases) and uteri (decreases), and based upon these findings, it was concluded that a substantial degree of organ recovery occurs during the 14 days following cessation of chemical exposures.
Mice. Mortality rates for high-dosage mice (sulfoxide, 5000 ppm; sulfone, 6000 ppm) were virtually 100% during the first 2 weeks of exposure in the 91-day study. Except for 1 male and 7 females dying in the 3000 ppm sulfoxide group during chemical exposures, there were no other mortalities noted. Eight mice were killed as aresult of fighting during a group housing trial on the fourth and fifth weeks of the study.
PCP SULFURS: SUBCIIRONIC EFFECTS Table 8 summarizes body weight depressions (up to 15%) in treated groups (750, 1500,3000 ppm) relative to control levels at the end of the 91-day exposure phase. These changes were not uniformly dose-related. Concomitantly, feed efficiency calculations provide disparate results. Values increased with exposure levels for sulfide-treated females, while feed efficiencies decreased with dosage for sulfone-treated males and females. At necropsy. weights of certain organs (those which exhibited significant changes from controls or were found to vary with dose) were normalized according to body weights (data not shown). Significant compound-related changes were seen only for the liver at the highest dose of each chemical (3000 ppm). hlaximal increases in 1iver:body weightratios for high-dosemice (relative tocontrols) wereseen in sulfoxidegroups (+45% -males; +45% -females) while the lowest increase was for sulfone males (+9%). Increases in remaining test groups ranged from +24 to 29%. Microscopic assessment of livers from treated mice disclosed lesions comparable to those seen in rats ( Table 9) . hlegalocytic changes in eentrilobular heptocytes were prominent at the 3000 ppm level of exposures, with the highest incidence seen in sulfoxide-treated mice. These changes persisted for the duration of the 14-day postexposure recovery period, and were similar to those induced by microsomal enzyme-inducing agents such as phenobarbital. The hexobarbital sleep-time experiment confirmed the hepatic enzyme-inducing properties of these test chemicals (see Dacre et al., 1993) . Necrotic foci were also observed in all high-dosage groups except sulfone-treated females. Vacuolar changes were seen in high-dosage sulfone-treated animals.
Lung changes were associated with chemical exposures. The respiratory epithelial lining of the bronchi and bronchioles were flattened and/or denuded, with occasional appearance of squamoid features one to two cell layers in depth. These changes were seen in all 3000 ppm sulfone-treated mice, and in 16% of the sulfide and sulfone high-dosage groups. Lungs of mid-and low-dosage groups were not examined. A NOEL cannot be reported in mice for this study.
Fourteen-day gavage study (rliestts titoilkeys)
Predominant signs of chemical intoxication in exposed rhesus monkeys were anorexia and depression with muscular weakness. One or both of these signs were seen at the lowest doses administered, except that 10 mgkg sulfoxide produced neither of these signs. Diarrhea and emesis were commonly seen in treated animals.
Clinical pathologic results for the three test chemicals are presented in Tables 10 and 11 . Chemical exposures induced elevated BUN values in high-dosage (320 mg/kg) groups. Glucose values were depressed in sulfide and sulfone high-dosage levels.
Organ weight data presented in Table 12 indicate chemically induced increases in liver and kidney weights. In addition, adrenal weight increases were observed following sulfide and sulfone administration. This latter finding may be associated with a stress response related to chemical exposures. Increases in brain and cardiac atrium weights without associated microscopic pathology, minor anomalies in the ECG results, and observed ocular lesions were deemed to be incidental to chemical exposures.
hlicroscopic lesions in rhesus monkeys were observed in association with chemical exposures (Tables 13-15 ).
The most significant were those in the lymphoid system, where nodular or diffuse proliferation of undifferentiated Iymphoreticular or histiocyte-like cells were present in lymph nodes and the white pulp of the spleen. In the lymph nodes, lesions involving germinal centers were characterized by irregular proliferation of cells in these areas with coalescence of adjacent nodules. The spleen lesions consisted of proliferations of histiocyte-like cells similar to those observed in lymph nodes, and were usually nodular with coalescence of adjacent nodules in more severely involved spleens. Nodular proliferations of lymphoreticular cells were also prominent in bone marrow, lymph nodes, and spleen of one animal treated at the lowest level of sulfoxide. Usually all lymph nodes examined were affected in involved animals. Lymphoid hyperplasia in the tonsil, and in some cases the thymus, was observed in affected animals. These lesions were observed in four monkeys; at least one was from each of the three compound groups. Diffuse proliferations (diagnosed as reactive hyperplasia) were also observed in moribund animals terminated on 9 or 10 days after being treated with 40 and 80 mglkg of sulfide, or 30 mgkg of sulfone.
Nodular lesions in lymph nodes, spleen, and bone marrow were observed in one 5 mglkg sulfoxide-treated monkey terminated on day 15. The lesions were diagnosed as a focal nodular lymphoma; however, the changes were early in development, and differentiation between hyperplasia and neoplasia was considered difficult. In addition to the lesions described, lymphoid depletion of lymph nodes or tonsils involving germinal centers specifically or as a more generalized lymphoid depletion observed in three animals from both high-and mid-dose groups of sulfone, and two from the high dose groups receiving sulfide or sulfoxide. Thymic atrophy and depletion were noted in animals from both the high-and middosage test groups. Liver lesions were common in higher-dosage monkeys for all three compounds but were most prominent after sulfide treatments. The lesions consisted of vacuolization of hepatocytes with or without degeneration or necrosis. The less severe lesions involved vacuolization of hepatocytes, which was either diffuse or of centrilobular distribution. The more severe lesions were characterized by vacuolarorgranulovacuolarcytoplasmic changes most prominent in ceritrilobular areas but occasionally extending diffusely throughout the liver parenchyma. Sinusoids were sometimes irregularly widened with evidence of degeneration and necrosis in individual hepatocytes, displaying indications of absolute losses of hepatocytes in the centrilobular areas. Hepatic lesions were most prominent in the higher-dosage animals, but occurred also in low-and middosage monkeys, especially those treated with sulfoxide. These changes were observed in both recovery and nonrecovery animals.
Kidney lesions were present in treated animals mainly at the highest dosage levels. The lesions consisted of deposition of brown granular pigment (interpreted to be lipofuscin pigment) in the basal portion of the proximal tubular epithelium. Vacuolization of proximal tubular epithelium was observed in three monkeys; one each in the mid-and high-dosage sulfide-treated groups, and one from the highest dosage sulfoxide group. Glomerular sclerosis was observed in two high-dosage sulfide-treated monkeys, but whether the lesions were associated with compound administration is uncertain. Adrenal cortical changes were prominent in monkeys treated with high-or intermediate-dosage chemicals. These lesions consisted of cortical hyperplasia, occasionally with areas of hemorrhage and congestion. In some instances, vacuolization or vacuolar degeneration was observed in cells of the zona fasciculata, and these were usually associated with areas of hemorrhage.
Thyroid glands of several animals contained changes consistent with follicular cell hyperplasia. A moderately large focus of follicular cell degeneration with hyperplasia and loss of thyroglobulin coIIoid occurred in a high-dosage sulfide-treated animal.
Digestive tract lesions were observed with the highest occurrence found in the high-dosage sulfide-treated group. Changes in the stomach consisted of vacuolar lesions with or without degeneration in the superficial lamina propria and occasionally the superficial epithelium. This was generally a diffuse lesions and present only in monkeys treated at the higher dosage levels. Degeneration and necrosis were also observed in gastric glands of several animals, and in some instances involved predominantly the parietal epithelial cells. Small intestinal lesions were consistent for all three compounds, and were observed most prominently in the high-dosage sulfide-treated group. These lesions consisted of vacuolization with occasional degeneration in the deepest layers of the crypts. In some cases, this appeared to involve primarily Paneth cells while in others it was not possible to determine if a specific cell type was involved. This change was often mild and difficult to discern from the vacuolar appearance normally present in control monkeys. There was evidence of changes suggesting increased cell turnover or cell migration in several animals, which appeared to result in mucosal degeneration characterized by shortening and fusing of villi and extension of mitotic activity further up the crypt than normal. These changes were seen more commonly in the ileum but were also present in the jejunum in one high-dosage sulfone-treated animal. Changes in the colon and rectum were relatively infrequent and consisted of mucosal degeneration, cell cycle alterations, or degeneration of surface epithelium, usually occurring in single animals at the high-or intermediate-dosage levels of these chemicals. One other lesion that was considered to be chemically induced was a diffuse depletion of zymogen granules observed in the pancreas of one high-dosage sulfide-treated animal. Other lesions observed were considered to be spontaneous due either to the nature of the lesions or their common occurrence in untreated monkeys.
DISCUSSION
Subchronic toxicity evaluations of p-chlorophenyl methyl-sulfide, -sulfoxide, and -sulfone were conducted in rodents and rhesus monkeys following oral exposures. In a 28-day gavage study in rats, dosage levels inducing increased mortality and other gross changes were defined.
Based upon survival, body weight changes, and feed consumption information, dietary levels of 4500 ppm and above were shown to cause significant toxic effects in rodents within a 28-day test period.
In 91-day dietary studies, body weight gains were suppressed in rats in a dose-related manner. Calculations of efficiencies with which test animals incorporated feed into body mass showed adiminution forrats in direct relation to chemical exposure levels. Only a very modest impact was observed at the lowest dosage (750 ppm) for all materials. Although body weights were similarly affected in mice, the feed efficiency did not display the same pattern as in rats (feed efficiencies increased with increased sulfide doses in females). The importance of this parameter as an identifier of systemic toxicity is somewhat unclear, although it does provide a normalization procedure in studies in which both body weight gains and feed consumptions are impaired by chemical exposures. None of the three test materials appeared to be significantly more toxic than the others according to this criterion. It was noted that feed consumptions approached those of control animals by the end of the 13 week studies, indicating that tolerance appears to have developed with time.
Although chemical exposures to rodents appeared to induce alterations in various hematologic parameters such as hemoglobin and hematocrit, there was no supportive evidence from microscopic observations of bone marrow or other hematopoietic tissues. These changes were also seen in monkeys. Certain clinical chemistry parameters were also found to be altered by compound exposures but these changes were not commensurate with minimal microscopic changes observed in applicable tissues. For example, the minimal severity of kidney changes seen in affected animals did not coincide with BUN elevations in high-dosage monkey groups. Decreases in SGOT in certain groups of rats suggest that the test chemicals' presence in serum may have interfered with the assay of this enzyme. Since serum assays were conducted following prolonged chemical exposure periods, a degree of organ tolerance may have developed to the liver effects of these materials, leading to nonelevated levels of serum enzymes. Liver changes were substantially different in rodents and monkeys. Predominant lesions in rodents were limited to hepatic megalocytosis with syncytial cell formation and necrosis. The large increases in liver weights and the indications of microsomal enzyme induction from hexobarbital sleep time studies in rats were consistent with microscopic findings. In contrast, monkeys displayed increases in serum SCOT and SGFT levels (particularly in sulfide-and sulfoxide-treated groups) along with hepatocyte vacuolation, degeneration, and necrosis with megalocytosis evident in only one animal. Alkaline phosphatase levels were depressed in both rodents and monkeys with an uncertain cause, since biliary ductal changes were not observed. Liver weight increases in monkeys were seen only at the highest dosage levels for each of the three test compounds.
Respiratory tract lesions (bronchiolarcpithclial degeneration) observed in mice are thought to have been derived from inhalation exposures. This species frequently sleeps in feed cups, and since these agents have moderate volatility, it is reasonable to suggest that this route of exposure contributed to lung findings observed since monkeys and rats were not similarly affected.
Species-specific toxic findings were lymphoreticular system and gastrointestinal lesions in the rhesus monkey. The former consisted of diffuse or nodular proliferations of large lymphoreticular cells involving lymph nodes, spleen, and bone marrow, and occurrcd in high-dosage animals dying or moribund as early as the ninth day of chemical exposure. Other lesions such as thymic atrophy and depletion, generalized lymphoid depletion, and lymphoreticular hypcrplasia were further evidence of the effects of these compounds in rhesus monkeys. Comparable findings were not seen in rodents following longer-term exposures. In addition, vacuolization and/or degenerative changes were present in the gastric mucosa and deep crypt areas of the small intestine. Hyperplasia and degeneration of the adrenal cortices and thyroid gland occurred at low frequencies in this species.
Many of the toxic changes and microscopic lesions reported in this study tended to return toward control levels during 14-day recovery periods. These included body weights, organ weights, and hepatic lesions in mice and monkeys. However, lesions such as the lymphoreticular changes in the monkey persisted to the end of the recovery "No effect" levels were not considered to be attained in either the rodent or monkey studies. However, the effects observed at the lowest dosages tested were considered minimal in severity, and are likely close to NOELS. The evidence for in vivo conversion of the sulfide andsulfoxide formsof these chemicals to the sulfoneprovides a basis for the qualitative similarities seen in the toxicities of these materials.
period.
